Publication:
Can Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?

Simple item page
dc.contributor.authorRuiz-Villaverde, Ricardo
dc.contributor.authorSánchez-Cano, Daniel
dc.date.accessioned2023-01-25T08:31:19Z
dc.date.available2023-01-25T08:31:19Z
dc.date.issued2016-01-01
dc.identifier.doi10.5152/balkanmedj.2015.15157
dc.identifier.issn2146-3123
dc.identifier.pmcPMC4767302
dc.identifier.pmid26966628
dc.identifier.pubmedURLhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767302/pdf
dc.identifier.unpaywallURLhttps://doi.org/10.5152/balkanmedj.2015.15157
dc.identifier.urihttp://hdl.handle.net/10668/9908
dc.issue.number1
dc.journal.titleBalkan medical journal
dc.journal.titleabbreviationBalkan Med J
dc.language.isoen
dc.organizationÁrea de Gestión Sanitaria Sur de Granada
dc.organizationAGS - Sur de Granada
dc.page.number115-6
dc.pubmedtypeJournal Article
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.titleCan Vemurafenib Induce Vitiligo in Metastatic Melanoma Patients?
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number33
dspace.entity.typePublication

Files

Collections

SAS - Hospital Santa Ana

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía